Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Reviews of Physiology, Biochemistry and Pharmacology 160

E-BookPDF1 - PDF WatermarkE-Book
125 Seiten
Englisch
Springer Berlin Heidelbergerschienen am15.05.20082008
Reviews of Physiology, Biochemistry and Pharmacology
Volume 160 2008

V. di Marzo: Endocannabinoids: Synthesis and Degradation
R. Rivera and J. Chun: Biological Effects of Lysophospholipids
S. J. O'Meara, K. Rodgers, and C. Godson: Lipoxins: Update and Impact of Endogenous Pro-Resolution Lipid Mediators
R.K.P. Benninger, M. Hao, and D. Piston: Multi-photon Excitation Imaging of Dynamic Processes in Living Cells and Tissues
G. Schmitz and M. Grandl: Lipid Homeostasis in Macrophages - Implications for Atherosclerosismehr
Verfügbare Formate
BuchGebunden
EUR106,99
BuchKartoniert, Paperback
EUR106,99
E-BookPDF1 - PDF WatermarkE-Book
EUR96,29

Produkt

KlappentextReviews of Physiology, Biochemistry and Pharmacology
Volume 160 2008

V. di Marzo: Endocannabinoids: Synthesis and Degradation
R. Rivera and J. Chun: Biological Effects of Lysophospholipids
S. J. O'Meara, K. Rodgers, and C. Godson: Lipoxins: Update and Impact of Endogenous Pro-Resolution Lipid Mediators
R.K.P. Benninger, M. Hao, and D. Piston: Multi-photon Excitation Imaging of Dynamic Processes in Living Cells and Tissues
G. Schmitz and M. Grandl: Lipid Homeostasis in Macrophages - Implications for Atherosclerosis
Details
Weitere ISBN/GTIN9783540776048
ProduktartE-Book
EinbandartE-Book
FormatPDF
Format Hinweis1 - PDF Watermark
FormatE107
Erscheinungsjahr2008
Erscheinungsdatum15.05.2008
Auflage2008
ReiheReviews of Physiology, Biochemistry and Pharmacology
Reihen-Nr.160
Seiten125 Seiten
SpracheEnglisch
IllustrationenIV, 125 p. 20 illus., 10 illus. in color.
Artikel-Nr.1430246
Rubriken
Genre9200

Inhalt/Kritik

Inhaltsverzeichnis
1;Endocannabinoids: synthesis and degradation;5
1.1;Endocannabinoids;5
1.2;Commonalities between anandamide and 2-AG anabolic and catabolic reactions;6
1.3;Anandamide biosynthesis: one or more pathways?;8
1.4;2-AG biosynthesis: perhaps less complicated than originally thought;10
1.5;Biosynthesis of NADA and other endocannabinoids: more questions than answers;12
1.6;The endocannabinoid membrane transporter: an unknown between release and re- uptake;12
1.7;Fatty acid amide hydrolase: AEA degradation and beyond;14
1.8;2-AG degradation: redundancy again;15
1.9;Endocannabinoid oxidation and its possible role;17
1.10;Regulation of endocannabinoid levels: what is the target, biosynthesis or degradation?;18
1.11;Conclusions: new therapeutic drugs from studies of endocannabinoid synthesis and degradation;20
1.12;References;21
2;Biological effects of lysophospholipids;29
2.1;Introduction;29
2.2;S1P receptors;32
2.3;LPA receptors;39
2.4;Conclusions and future prospects;44
2.5;References;45
3;Lipoxins: update and impact of endogenous pro- resolution lipid mediators;51
3.1;Introduction;51
3.2;Lipoxin biosynthesis and metabolism;52
3.3;Resolvins;53
3.4;Metabolism;53
3.5;Bioactions of lipoxins;54
3.6;Mechanisms of lipoxin action: receptors and signalling pathways;55
3.7;Transcription factors involved in lipoxin A4 signalling;62
3.8;Lipoxins in inflammation and disease;63
3.9;Intestinal inflammation;64
3.10;Respiratory disease;65
3.11;Glomerulonephritis and renal diseases;65
3.12;Angiogenesis;66
3.13;Tuberculosis;67
3.14;Ocular wound healing;67
3.15;Conclusions;68
3.16;References;68
4;Multi-photon excitation imaging of dynamic processes in living cells and tissues;75
4.1;Introduction;76
4.2;Two-photon absorption and the two-photon microscope;77
4.3;Applications of two-photon microscopy;79
4.4;The future;91
4.5;References;93
5;Lipid homeostasis in macrophages - Implications for atherosclerosis;97
5.1;Macrophages and atherosclerosis;99
5.2;Differential expression of the monocyte innate immunity receptor complex defining monocyte subpopulations;101
5.3;Receptor entry pathways of modified LDL;103
5.4;Specific characteristics of E-LDL and Ox-LDL;105
5.5;Abnormalities of cholesterol trafficking;108
5.6;Cellular cholesterol metabolism and lipid storage;109
5.7;Cholesterol efflux from macrophages to prevent foam cell formation;111
5.8;ABCA1-interacting proteins and lipid membrane microdomains;113
5.9;Regulation of cellular cholesterol levels through transcription factors;115
5.10;Niacin, statins, CETP inhibitors, apoA-I mimetics, and ezetimibe as pharmacological modulators of lipid homeostasis;117
5.11;Conclusion;118
5.12;Glossary;119
5.13;References;120mehr

Autor